Global antibiotic reduction shows minimal impact on bacterial infection deaths

Reducing global human antibiotic consumption by 10% would reduce total bacterial infection deaths by only a very small percentage, PLOS Medicine reported. Researchers Benjamin J. Singer, Alec Gleason, Isabella Impalli, Mikkel D. Nagorsen, Chungman Chae, Lauren C. Granskog, Philip C. Lee, Ramanan Laxminarayan, and Joseph A. Lewnard conducted an observational study to evaluate how changes in human antibiotic use affect the burden and prevalence of antimicrobial resistance in bacterial pathogens. [1]

Human antibiotic use is widely believed to contribute to the evolution and maintenance of antimicrobial resistance in bacteria. According to PLOS Medicine, antibiotic stewardship efforts aim to discourage antibiotic use when the harms related to antimicrobial resistance outweigh the clinical benefits. However, empirical evidence to inform these assessments has remained limited. [1]

The findings build on ongoing public health research into how environmental factors and biological mechanisms influence human disease outcomes. As FTMQ Health reported earlier, previous human observational studies have identified links between dietary sugars and diabetes risk, as well as distinct microbiome alterations in patients suffering from severe long COVID symptoms. [2][3]

The authors of the observational study emphasized that understanding the exact relationship between modifiable antibiotic consumption and resistance levels is critical for designing effective public health stewardship policies worldwide. [1]